Remove 2007 Remove Government Remove Individual Remove Provider
article thumbnail

MN Legislative Session 2025: Updates on Health Care Bills

Minnesota Academy of Family Physicians

As we move into the tenth week of the legislative session, Minnesota Academy of Family Physicians (MAFP) lobbyist Megan Verdeja breaks down what’s happening at the Minnesota State Capitol and provides an update on health care bills. The bill passed by a voice vote and was referred to the State and Local Government Committee.

article thumbnail

Risking It All For a New Business Model at Family Physicians of St. Joe

Family Physicians of St. Joseph

Joseph, the family medicine practice is committed to providing exceptional, affordable, patient-centered primary care in SW Michigan without reliance on insurance companies for payment of services. The individuals who make up the practice impact the community in a variety of ways. Joseph, P.C., Anchored at 147 Peace Boulevard in St.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law Blog

Though the carve-out seems at odds with FDA’s regulations requiring generic drugs to have the “same labeling” as their RLDs, such regulations specifically provide for differences arising from carved-out, patent-protected method of use. Teva received tentative approval in June 2003 and launched in 2007 after a blocking patent expired.

IT 52
article thumbnail

Health and Wealth Shocks: Lauren Hunt, Rebecca Rodin, Tsai-Chin Cho

GeriPal

And the government can do something about that?!? Those are all things that could dramatically be a major health shock for an individual. And so spouses are typically the ones for patients who provide most of the caregiving support. Wait, so one key message is that social health is linked to physical and cognitive health?!?

Illness 63
article thumbnail

Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution

FDA Law Blog

Specifically, these are procedures and drugs used in providing what HHS had, until recently, referred to as gender-affirming care. Department of Health & Human Services purporting to provide a comprehensive review of the evidence and best practices for promoting the health of children and adolescents with gender dysphoria.